Physician profile
Daniel William Flis
NPI 1316266042
$4,781.10
in general payments reported to CMS, 2019-2025
15 companies · $4,124 in 2025
The $4,124 reported for 2025 was more than what 95% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $132 · 2021: $60.25 · 2022: $21.22 · 2023: $63.19 · 2024: $236 · 2025: $4,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $422.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,032.00 | 2025 | |
| Stryker Corporation | $242.57 | 2019-2024 | Hemopore, Scopis Ent |
| Smith+Nephew, INC. | $154.59 | 2020-2024 | Tula, Halo |
| Takeda Pharmaceuticals U.S.A., INC. | $53.21 | 2024-2025 | Cuvitru |
| Optinose US, INC. | $44.11 | 2019-2022 | |
| Medtronic USA, INC. | $40.00 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $36.11 | 2025 | Dupixent |
| Getinge USA Sales, LLC | $28.94 | 2025 | Ultima Activator II Drive Mechanism |
| Genzyme Corporation | $28.00 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $24.88 | 2024 | Fasenra |
| Tactile Systems Technology INC | $21.51 | 2019 | |
| Intersect Ent, INC. | $21.16 | 2020 | |
| Cook Medical LLC | $19.06 | 2019 | |
| Cochlear Americas | $17.90 | 2024 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Ethicon US, LLC | $17.06 | 2023 | Stratafix, Harmonic, Dermabond Prineo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Flis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.